reference/9576892

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9576892

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	633
issn	1747-0285 1747-0277
issueIdentifier	4
pageRange	620-633
publicationName	Chemical Biology & Drug Design
startingPage	620
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_7189423fcbc9ae0f00105278cfe10e33 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a998e811f01067fe4c6518f9e6dff2e3 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_2464d55c156bf133de0f59cfe5492645 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b218791a692a29edfcef936c304d269c http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_96399cf467d751009df55ca07098ae89
bibliographicCitation	Dahal A, Lo M, Singh S, Vo H, ElHage D, Jois SD, Murru S. 1,3-diarylpyrazolones as potential anticancer agents for non-small cell lung cancer: Synthesis and antiproliferative activity evaluation. Chem Biol Drug Des. 2022 Apr;99(4):620–33. PMID: 35156777; PMCID: PMC10127554.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5d9ca4c8cc7020e054b7ed43102c096 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1956-3079 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1c26a3ff8c5f6c83e027e6f2eb4fe3cf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0c9281dc75e7d46ad6fed375d74b6dfd http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6936-772X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ba790e044eeec743de3ef0931f2e298c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9213139f0b179a55dfbe594d09f5018c
date	202203
identifier	https://pubmed.ncbi.nlm.nih.gov/35156777 https://doi.org/10.1111/cbdd.14030 https://pubmed.ncbi.nlm.nih.gov/PMC10127554
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32796 https://portal.issn.org/resource/ISSN/1747-0277 https://portal.issn.org/resource/ISSN/1747-0285
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	1,3‐diarylpyrazolones as potential anticancer agents for non‐small cell lung cancer: Synthesis and antiproliferative activity evaluation
discusses	http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0456294
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D002289Q000473 http://id.nlm.nih.gov/mesh/D002289Q000188 http://id.nlm.nih.gov/mesh/D008175Q000473 http://id.nlm.nih.gov/mesh/D008175Q000188 http://id.nlm.nih.gov/mesh/D000970 http://id.nlm.nih.gov/mesh/D047069Q000494
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D004354 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D049109 http://id.nlm.nih.gov/mesh/D017209 http://id.nlm.nih.gov/mesh/D013329
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10184653 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11513733 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123631 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6650

Total number of triples: 53.